Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$43,353.00
Dec 20, 2020
For-profit organization
Innovation Assistance Program – Round 2.5
965916
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$661,400.00
Jul 1, 2020
For-profit organization
Isolation and characterization of neuromodulatory and immunomodulatory mediators from bacteria for application in patients with PANS/PANDAS.
956002
Adapsyn’s proprietary drug discovery platform will be applied to the screening of bacteria to discover neuro- and immunomodulatory small molecules to develop therapeutic agents for the treatment of childhood neuropsychiatric disorders.
$97,408.00
Jun 25, 2020
For-profit organization
Innovation Assistance Program – Round 2
960215
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$81,312.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
950480
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
$301,000.00
Mar 15, 2020
For-profit organization
5118520201023
5118520201023
RRRF funding will be used to support Recipients to address the impacts of the COVID-19 pandemic.
$72,000.00
Feb 1, 2019
For-profit organization
Isolation/characterization of neuromodulatory and immunomodulatory mediators for PANS/PANDAS.
914152
Bacterial strains from the human microbiome will be screened for the production of secondary metabolites with the potential to influence the human nervous and immune systems, for potential application in childhood neuropsychiatric disorders.